Literature DB >> 28618135

Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation.

Zhan-Yi Sun1, Pu-Guang Chen1, Yan-Fang Liu1, Lei Shi1, Bo-Dou Zhang1, Jun-Jun Wu1, Yu-Fen Zhao1, Yong-Xiang Chen1, Yan-Mei Li1.   

Abstract

Immunotherapy has become one of the most promising therapies for the treatment of diseases. Synthetic immunostimulants and nanomaterial immunostimulant systems are indispensable for the activation of the immune system in cancer immunotherapy. Herein, a strategy for preparing self-assembled nano-immunostimulants (SANIs) for synergistic immune activation is reported. Three immunostimulants self-assemble into nanoparticles through electrostatic interactions. SANIs showed strong synergistic immunostimulation in macrophages. SANIs could also induce a strong antitumor immune response to inhibit tumor growth in mice and act as an efficient adjuvant of antitumor vaccines. Therefore, SANIs may be generally applied in cancer immunotherapy. This novel SANI strategy provides a new way for the development of both immunostimulants and -suppressants.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibodies; cancer; immunochemistry; nanoparticles; self-assembly

Mesh:

Substances:

Year:  2017        PMID: 28618135     DOI: 10.1002/cbic.201700246

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  Therapeutic applications of toll-like receptors (TLRs) agonists in AML.

Authors:  Ye Peng; Yanzhong Wang; Manling Wang; Jianping Lan; Yirui Chen
Journal:  Clin Transl Oncol       Date:  2022-08-13       Impact factor: 3.340

2.  STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation.

Authors:  Bo-Dou Zhang; Jun-Jun Wu; Wen-Hao Li; Hong-Guo Hu; Lang Zhao; Pei-Yang He; Yu-Fen Zhao; Yan-Mei Li
Journal:  Nano Res       Date:  2022-04-18       Impact factor: 10.269

Review 3.  Engineering Targeting Materials for Therapeutic Cancer Vaccines.

Authors:  Priscilla S Briquez; Sylvie Hauert; Alexandre de Titta; Laura T Gray; Aaron T Alpar; Melody A Swartz; Jeffrey A Hubbell
Journal:  Front Bioeng Biotechnol       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.